IKJ Capital
Overview
IKJ Capital is a venture capital firm founded in 2019 and based in Sao Paulo, Brazil. The firm invests in early-stage healthcare technology companies in Latin America and North America, focusing on areas such as mental health, chronic conditions, and longevity. It manages funds including IKJ Health Innovation I and II.
Portfolio Companies
4
Website
ikjcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Eli Health | Jun 2025 | Series A | Co-investor |
| Perceiv AI | Dec 2022 | Seed | Co-investor |
| Portal Biotechnologies | Dec 2024 | Seed | Co-investor |
| Mevo | Sep 2024 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is IKJ Capital based?
IKJ Capital is headquartered in São Paulo, São Paulo, Brazil.
When was IKJ Capital founded?
Founding year information for IKJ Capital is not publicly available.
How many portfolio companies does IKJ Capital have?
IKJ Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in IKJ Capital's portfolio?
Portfolio companies visible on Caplight include Eli Health, Perceiv AI, Portal Biotechnologies, Mevo.
What was IKJ Capital's most recent investment shown here?
IKJ Capital's most recent investment in this portfolio sample was in Eli Health in 2025.
What sectors does IKJ Capital focus on?
IKJ Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does IKJ Capital focus on?
IKJ Capital typically invests at the Early stage.